Management of patients with hepatitis C virus resistance–associated variants to NS5A inhibitors: Where are we now?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 4, 2015-10 ,pp. : 82-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effective epitope identification employing phylogenetic, mutational variability, sequence entropy, and correlated mutation analysis targeting NS5B protein of hepatitis C virus: from bioinformatics to therapeutics

By  

JOURNAL OF MOLECULAR RECOGNITION (ELECTRONIC), Vol. 28, Iss. 8, 2015-08 ,pp. : 492-505

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Docking and Dynamics Simulation Study on the Influence of Zn2+ on the Binding Modes of Aggrecanase with its Inhibitors

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 17, Iss. 10, 2014-12 ,pp. : 891-903

Bentham Science Publishers

Access to resources Recommend Favorite

P2‐Quinazolinones and Bis‐Macrocycles as New Templates for Next‐Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK‐2748 and MK‐6325

By  

CHEMMEDCHEM, Vol. 10, Iss. 4, 2015-04 ,pp. : 727-735

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influences Analysis of Nanometric Cutting Single-Crystal Copper via Molecular Dynamics Simulation

By Zhang Lin   Zhao Hongwei   Zhang Peng   Shi Chengli  

Journal of Computational and Theoretical Nanoscience, Vol. 10, Iss. 10, 2013-10 ,pp. : 2462-2472

American Scientific Publishers

Access to resources Recommend Favorite